Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Wen Lin

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of Hepatology|December 11, 2012
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosisChih-Wen Lin, Chih-Che Lin, Lein-Ray Mo, et al.
Clinical and Translational Gastroenterology|July 3, 2018
Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resectionChih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.
Biomaterials|June 27, 2013
EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapyHung-Wei Yang, Yu-Jen Lu, Kun-Ju Lin, et al.
BMC Gastroenterology|May 15, 2021
Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysisYaw-Sen Chen, Pei-Min Hsieh, Hung-Yu Lin, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 29, 2013
Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxideHung-Wei Yang, Mu-Yi Hua, Tsong-Long Hwang, et al.
Hepatology Communications|November 2, 2022
NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppressionYa-Chin Wang, Ming-Chao Tsai, Yaw-Sen Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2025
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort studyTeng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Clinical and Molecular Hepatology|February 5, 2025
Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort studyShou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 7, 2025
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis CYen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|December 11, 2012
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosisChih-Wen Lin, Chih-Che Lin, Lein-Ray Mo, et al.
Clinical and Translational Gastroenterology|July 3, 2018
Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resectionChih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.
Biomaterials|June 27, 2013
EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapyHung-Wei Yang, Yu-Jen Lu, Kun-Ju Lin, et al.
BMC Gastroenterology|May 15, 2021
Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysisYaw-Sen Chen, Pei-Min Hsieh, Hung-Yu Lin, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 29, 2013
Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxideHung-Wei Yang, Mu-Yi Hua, Tsong-Long Hwang, et al.
Hepatology Communications|November 2, 2022
NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppressionYa-Chin Wang, Ming-Chao Tsai, Yaw-Sen Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2025
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort studyTeng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Clinical and Molecular Hepatology|February 5, 2025
Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort studyShou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 7, 2025
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis CYen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, et al.
Pageof 11